Phase 4 Study on the Prognosis and Effect of Anti-Diabetic Drugs on Type-2 Diabetes Mellitus With Coronary Artery Disease.

Trial Profile

Phase 4 Study on the Prognosis and Effect of Anti-Diabetic Drugs on Type-2 Diabetes Mellitus With Coronary Artery Disease.

Completed
Phase of Trial: Phase IV

Latest Information Update: 15 Jan 2014

At a glance

  • Drugs Glipizide (Primary) ; Metformin (Primary)
  • Indications Cardiovascular disorders; Coronary artery disease; Myocardial infarction; Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Acronyms SPREAD-DIMCAD
  • Most Recent Events

    • 12 Jun 2012 Results presented at the 72nd Annual Scientific Sessions of the American Diabetes Association.
    • 21 Apr 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 06 Sep 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top